Q3 2024 |
1,050 |
$2.07B |
+$1.26B |
-$790M |
+$467M |
EEM, MSFT, NVDA, SPOT, META
|
13F-HR |
11/14/2024, 04:13 PM |
Q2 2024 |
970 |
$1.53B |
+$1.07B |
-$633M |
+$435M |
HYG, AAPL, XLF, XOM, UNH
|
13F-HR |
8/14/2024, 04:06 PM |
Q1 2024 |
914 |
$1.09B |
+$687M |
-$645M |
+$42.5M |
WDAY, PXD, CME, HES, AAPL
|
13F-HR |
5/15/2024, 04:21 PM |
Q4 2023 |
958 |
$994M |
+$810M |
-$176M |
+$634M |
EMB, HYG, QQQ, HD, SPIB
|
13F-HR |
2/14/2024, 04:06 PM |
Q3 2023 |
326 |
$319M |
+$124M |
-$309M |
-$184M |
EWZ, CME, MRNA, XLF, EMB
|
13F-HR |
11/14/2023, 04:24 PM |
Q2 2023 |
153 |
$542M |
+$235M |
-$141M |
+$93.5M |
TLT, EMB, EWZ, EEM, URA
|
13F-HR |
8/14/2023, 04:15 PM |
Q1 2023 |
91 |
$448M |
+$194M |
-$88M |
+$106M |
EMB, TLT, MRNA, LQD, CME
|
13F-HR |
5/15/2023, 04:21 PM |
Q4 2022 |
71 |
$343M |
+$146M |
-$101M |
+$44.9M |
MRNA, HYG, LQD, EMB, URA
|
13F-HR |
2/14/2023, 04:49 PM |
Q3 2022 |
59 |
$263M |
+$170M |
-$31.3M |
+$139M |
MRNA, XLE, EMB, HYG, CME
|
13F-HR |
11/14/2022, 04:22 PM |
Q2 2022 |
36 |
$137M |
+$77.3M |
-$62M |
+$15.3M |
MRNA, URA, CME, TRTX, CNDWS
|
13F-HR |
8/15/2022, 04:37 PM |
Q1 2022 |
25 |
$133M |
+$74.1M |
-$58.2M |
+$15.8M |
CME, URA, BIDU, IJH, MRNA
|
13F-HR |
5/16/2022, 04:33 PM |
Q4 2021 |
17 |
$114M |
+$32.6M |
-$87.6M |
-$55M |
GDX, CME, BIDU, VALE, URA
|
13F-HR |
2/14/2022, 04:46 PM |
Q3 2021 |
28 |
$165M |
+$78.5M |
-$19.5M |
+$59.1M |
QQQ, GDX, BIDU, CME, EEM
|
13F-HR |
11/12/2021, 04:15 PM |
Q2 2021 |
29 |
$120M |
+$17.5M |
-$49.9M |
-$32.4M |
GDX, CME, BIDU, NET, QCLN
|
13F-HR |
8/13/2021, 04:07 PM |
Q1 2021 |
33 |
$150M |
+$60.7M |
-$73.7M |
-$13M |
GDX, PBR, CME, KOPN, NET
|
13F-HR |
5/14/2021, 04:37 PM |
Q4 2020 |
19 |
$172M |
$0 |
$0 |
|
GDX, CME, TWST, TUR, QCLN
|
13F-HR |
2/12/2021, 05:15 PM |
Q3 2017 |
30 |
$43.5M |
+$23.1M |
-$420K |
+$22.7M |
CME, LQD, EMB, CBLAQ, TWX
|
13F-HR |
11/14/2017, 04:14 PM |
Q2 2017 |
3 |
$19.7M |
+$6.88M |
$0 |
+$6.88M |
CME, LQD, CBLAQ
|
13F-HR |
8/14/2017, 04:29 PM |
Q1 2017 |
1 |
$12.2M |
$0 |
-$22M |
-$22M |
CME
|
13F-HR |
5/15/2017, 01:21 PM |
Q4 2016 |
2 |
$33.9M |
$0 |
-$67.6M |
-$67.6M |
IBB, CME
|
13F-HR |
2/14/2017, 12:23 PM |
Q3 2016 |
12 |
$102M |
+$91.6M |
-$25.2M |
+$66.3M |
IBB, PBR, CME, BHI, HAL
|
13F-HR |
11/14/2016, 04:44 PM |
Q2 2016 |
3 |
$35.2M |
$0 |
-$173M |
-$173M |
EEM, CME, OCN
|
13F-HR |
8/15/2016, 04:14 PM |
Q1 2016 |
13 |
$208M |
+$44.7M |
-$43.3M |
+$1.46M |
YPF, EEM, AGRO, CRESY, PAM
|
13F-HR |
5/16/2016, 04:15 PM |
Q4 2015 |
12 |
$198M |
+$45M |
-$81.1M |
-$36.1M |
YPF, AGRO, PAM, TX, CRESY
|
13F-HR |
2/16/2016, 04:09 PM |
Q3 2015 |
19 |
$198M |
+$68M |
-$136M |
-$67.8M |
YPF, PAM, AGRO, GGAL, CRESY
|
13F-HR |
11/16/2015, 04:12 PM |
Q2 2015 |
27 |
$302M |
+$180M |
-$32.3M |
+$148M |
YPF, AGRO, PAM, CMA, JPM
|
13F-HR |
8/14/2015, 04:14 PM |
Q1 2015 |
16 |
$161M |
+$98.5M |
-$111M |
-$12.8M |
YPF, AAXJ, MCHI, AGRO, CME
|
13F-HR |
5/15/2015, 04:37 PM |
Q4 2014 |
8 |
$170M |
+$156M |
-$225M |
-$69.1M |
SPY, YPF, AAXJ, CME, MCHI
|
Restatement |
2/19/2015, 03:21 PM |
Q3 2014 |
9 |
$238M |
+$200M |
-$88.3M |
+$111M |
FXI, GLD, VXX, KRE, EEM
|
13F-HR |
11/14/2014, 04:48 PM |
Q2 2014 |
9 |
$127M |
+$43.4M |
-$62.6M |
-$19.2M |
PKW, XLF, GLD, EWZ, EEM
|
13F-HR |
8/14/2014, 04:44 PM |
Q1 2014 |
11 |
$144M |
+$82.5M |
-$137M |
-$54M |
PKW, FXI, XRT, EEM, XLF
|
13F-HR |
5/15/2014, 04:41 PM |
Q4 2013 |
14 |
$207M |
$0 |
$0 |
|
FXI, GLD, XRT, EEM, CME
|
13F-HR |
2/14/2014, 04:22 PM |